
The use of human zzso zzso zzso has been approved by the Food and Drug Administration zzso in patients with anemia and zzso Although good results have been zzso it is too expensive to permit its use zzso For the purpose of evaluating the therapeutic effect of zzso including zzso zzso response variables and quality of life zzso a prospective trial was carried out in patients with anemia and zzso zzso zzso zzso zzso zzso zzso and quality of life were zzso A total of 36 patients were treated in the protocol zzso were zzso 16 men and 20 women, with a medium age zzso years; 27 patients were treated with chemotherapy (16 with zzso 15 patients presented zzso zzso In zzso patients an increase in the level of zzso was zzso and in zzso its zzso was zzso zzso requirements were reduced by zzso The zzso increase greater than zzso zzso at the second week of treatment was the most significant variable of early zzso Patients treated with zzso zzso zzso lower than 1,100 zzso and those without zzso zzso zzso responded zzso zzso zzso zzso zzso zzso and zzso and zzso count at the second week did not correlate with zzso Quality of life parameters were better in patients with good response to zzso It can be concluded that good results in the treatment of patients with anemia and cancer are obtained with zzso 

